Anti-CD350/FZD10 Antibody (SAA2393) from ProteoGenix; catalogue ARO-A22840; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The Anti-CD350/FZD10 Antibody (SAA2393) is a highly specific and reliable tool for biotech research. With its unique binding ability, this antibody targets CD350/FZD10, a transmembrane receptor protein that plays a crucial role in various biological processes.
CD350/FZD10 is a member of the Frizzled family of G protein-coupled receptors (GPCRs) and is known to be involved in the Wnt signaling pathway. This pathway is responsible for regulating cell proliferation, differentiation, and apoptosis, making CD350/FZD10 a key player in various cellular processes. The Anti-CD350/FZD10 Antibody (SAA2393) specifically binds to this receptor, allowing for targeted and precise research.
The Anti-CD350/FZD10 Antibody (SAA2393) has a wide range of applications in the biotech field. It can be used in studies related to cancer, as CD350/FZD10 has been found to be overexpressed in various types of cancer, including breast, colon, and lung cancer. This antibody can also be used in neurological research, as CD350/FZD10 has been linked to neurodegenerative diseases such as Alzheimer’s and Parkinson’s.
The Anti-CD350/FZD10 Antibody (SAA2393) has been extensively tested and validated for use in various experimental techniques, including Western blotting, immunofluorescence, and flow cytometry. Its high specificity and sensitivity make it an ideal tool for identifying and studying CD350/FZD10 expression in different cell lines and tissues.
With the Anti-CD350/FZD10 Antibody (SAA2393), researchers can confidently explore the role of CD350/FZD10 in various biological processes and diseases, leading to a better understanding of its function and potential therapeutic targets.
Incorporating the Anti-CD350/FZD10 Antibody (SAA2393) into your research will provide you with accurate and reliable results, helping you advance your scientific discoveries and contribute to the field of biotechnology.
Don’t miss out on this valuable tool for targeted biotech research. Order your Anti-CD350/FZD10 Antibody (SAA2393) today and take your research to the next level.
ProteoGenix catalogue number ARO-A22840. For research use only.
Target: Frizzled-10, Fz-10, hFz10, FzE7, CD350, FZD10; Clonality: Monoclonal Antibody; Applications: ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA |
|---|---|---|---|---|---|---|---|---|
| Frizzled-10, Fz-10, hFz10, FzE7, CD350, FZD10 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
